A placebo-controlled double blind trial of etanercept for the cancer anorexia/weight loss syndrome : Results from N00C1 from the north central cancer treatment groupJATOI, Aminah; DAKHIL, Shaker R; LOPRINZI, Charles L et al.Cancer. 2007, Vol 110, Num 6, pp 1396-1403, issn 0008-543X, 8 p.Article

Randomized comparison of a nicotine inhaler and bupropion for smoking cessation and relapse preventionCROGHAN, Ivana T; HURT, Richard D; TSCHETTER, Loren K et al.Mayo Clinic proceedings. 2007, Vol 82, Num 2, pp 186-195, issn 0025-6196, 10 p.Article

Intravenous Calcium and Magnesium for Oxaliplatin-Induced Sensory Neurotoxicity in Adjuvant Colon Cancer: NCCTG N04C7GROTHEY, Axel; NIKCEVICH, Daniel A; LOPRINZI, Charles L et al.Journal of clinical oncology. 2011, Vol 29, Num 4, pp 421-427, issn 0732-183X, 7 p.Article

A Front-Line Window of Opportunity Phase 2 Study of Sorafenib in Patients With Advanced Nonsmall Cell Lung Cancer: North Central Cancer Treatment Group Study N0326DY, Grace K; HILLMAN, Shauna L; ROWLAND, Kendrith M et al.Cancer. 2010, Vol 116, Num 24, pp 5686-5693, issn 0008-543X, 8 p.Article

Randomized controlled trial to evaluate transdermal testosterone in female cancer survivors with decreased libido; north central cancer treatment group protocol N02C3BARTON, Debra L; WENDER, Donald B; CARPENTER, Paul C et al.Journal of the National Cancer Institute. 2007, Vol 99, Num 9, pp 672-679, issn 0027-8874, 8 p.Article

Results of a phase II study of high-dose thoracic radiation therapy with concurrent cisplatin and etoposide in limited-stage small-cell lung cancer (NCCTG 95-20-53)SCHILD, Steven E; BANNER, James A; WENDER, Donald B et al.Journal of clinical oncology. 2007, Vol 25, Num 21, pp 3124-3129, issn 0732-183X, 6 p.Article